BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9056167)

  • 1. Net fluxes over working thigh of hormones, growth factors and biomarkers of bone metabolism during short lasting dynamic exercise.
    Brahm H; Piehl-Aulin K; Saltin B; Ljunghall S
    Calcif Tissue Int; 1997 Feb; 60(2):175-80. PubMed ID: 9056167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency.
    Bollerslev J; Møller J; Thomas S; Djøseland O; Christiansen JS
    Eur J Endocrinol; 1996 Dec; 135(6):666-71. PubMed ID: 9025710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of short-term maximal work on plasma calcium, parathyroid hormone, osteocalcin and biochemical markers of collagen metabolism.
    Kristoffersson A; Hultdin J; Holmlund I; Thorsen K; Lorentzon R
    Int J Sports Med; 1995 Apr; 16(3):145-9. PubMed ID: 7649703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M; Fukunaga M; Ohtawa T; Harada T
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor axis, bone and collagen turnover in children with atopic dermatitis treated with topical glucocorticosteroids.
    Wolthers OD; Heuck C; Ternowitz T; Heickendorff L; Nielsen HK; Frystyk J
    Dermatology; 1996; 192(4):337-42. PubMed ID: 8864369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical markers of bone metabolism during distance running in healthy, regularly exercising men and women.
    Brahm H; Piehl-Aulin K; Ljunghall S
    Scand J Med Sci Sports; 1996 Feb; 6(1):26-30. PubMed ID: 8680940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia.
    Crofton PM; Ahmed SF; Wade JC; Stephen R; Elmlinger MW; Ranke MB; Kelnar CJ; Wallace WH
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3121-9. PubMed ID: 9745414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test.
    Ehrnborg C; Lange KH; Dall R; Christiansen JS; Lundberg PA; Baxter RC; Boroujerdi MA; Bengtsson BA; Healey ML; Pentecost C; Longobardi S; Napoli R; Rosén T;
    J Clin Endocrinol Metab; 2003 Jan; 88(1):394-401. PubMed ID: 12519882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults--an 18-month randomised, placebo-controlled, double blinded trial.
    Sneppen SB; Hoeck HC; Kollerup G; Sørensen OH; Laurberg P; Feldt-Rasmussen U
    Eur J Endocrinol; 2002 Feb; 146(2):187-95. PubMed ID: 11834427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in bone mass and serum markers of bone metabolism after parathyroidectomy.
    Thorsen K; Kristoffersson AO; Lorentzon RP
    Surgery; 1997 Nov; 122(5):882-7. PubMed ID: 9369887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal serum indices of bone collagen biosynthesis and degradation in small for gestational age infants.
    Namgung R; Tsang RC; Sierra RI; Ho ML
    J Pediatr Gastroenterol Nutr; 1996 Oct; 23(3):224-8. PubMed ID: 8890070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.
    Magnusson P; Degerblad M; Sääf M; Larsson L; Thorén M
    J Bone Miner Res; 1997 Feb; 12(2):210-20. PubMed ID: 9041052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome.
    Klinger B; Jensen LT; Silbergeld A; Laron Z
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):423-9. PubMed ID: 8959080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men.
    Gram J; Junker P; Nielsen HK; Bollerslev J
    Bone; 1998 Sep; 23(3):297-302. PubMed ID: 9737353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM; Jehle DR; Mohan S; Böhm BO
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of serum concentrations of biochemical markers of bone metabolism and insulin-like growth factor I associated with treadmill exercise in young horses.
    Jackson BF; Goodship AE; Eastell R; Price JS
    Am J Vet Res; 2003 Dec; 64(12):1549-56. PubMed ID: 14672435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone metabolism during exercise and recovery: the influence of plasma volume and physical fitness.
    Brahm H; Piehl-Aulin K; Ljunghall S
    Calcif Tissue Int; 1997 Sep; 61(3):192-8. PubMed ID: 9262509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal bone turnover in monoclonal gammopathy of undetermined significance: analyses of type I collagen telopeptide, osteocalcin, bone-specific alkaline phosphatase and propeptides of type I and type III procollagens.
    Vejlgaard T; Abildgaard N; Jans H; Nielsen JL; Heickendorff L
    Eur J Haematol; 1997 Feb; 58(2):104-8. PubMed ID: 9111591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.